Atherosclerosis Risk in Communities (ARIC)

This study has been completed.

First Received: May 25, 2000 Last Updated: April 13, 2009 History of Changes

Sponsor:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00005131

Purpose

To measure associations of established and suspected coronary heart disease risk factors with both atherosclerosis and new coronary heart disease events in representative cohorts from four diverse United States communities. To compare the communities with respect to risk factors, medical care, atherosclerosis, and coronary heart disease incidence. ARIC has two components in each community: study of representative cohorts of adult men and women, and community surveillance of morbidity and mortality.

Condition	Phase
Atherosclerosis Coronary Disease Coronary Heart Disease Risk Reduction Diabetes Mellitus Cardiovascular Diseases Heart Diseases Heart Failure, Congestive Heart Failure	N/A

Study Type:

Observational

Resource links provided by NLM:

MedlinePlus related topics: Coronary Artery Disease Diabetes Heart Diseases Heart Failure

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	July 1985
Study Completion Date:	January 2007
Primary Completion Date:	January 2007 (Final data collection date for primary outcome measure)

Show Detailed Description

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

No eligibility criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005131

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Investigator:	Christie Ballantyne	Baylor College of Medicine
Investigator:	Lloyd Chambless	University of North Carolina
Investigator:	Josef Coresh	Johns Hopkins University
Investigator:	Matthew Davis	University of Wisconsin, Madison
Investigator:	Aaron Folsom	University of Minnesota - Clinical and Translational Science Institute
Investigator:	Gerardo Heiss	University of North Carolina
Investigator:	Daniel Jones	University of Mississippi Medical Center
Investigator:	Kenneth Wu	Texas Health Science Center

More Information

Additional Information:

Related Info This link exits the ClinicalTrials.gov site

No publications provided by National Heart, Lung, and Blood Institute (NHLBI)

Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):

Yang EY, Nambi V, Tang Z, Virani SS, Boerwinkle E, Hoogeveen RC, Astor BC, Mosley TH, Coresh J, Chambless L, Ballantyne CM. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2009 Dec 15;54(25):2388-95.

Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC Jr; ARIC Investigators. Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2009 Feb 3;119(4):503-14. Epub 2009 Jan 19.

Study ID Numbers:	1001
Study First Received:	May 25, 2000
Last Updated:	April 13, 2009
ClinicalTrials.gov Identifier:	NCT00005131 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Atherosclerosis
Arterial Occlusive Diseases
Heart Failure
Heart Diseases
Metabolic Diseases
Myocardial Ischemia
Diabetes Mellitus

Vascular Diseases
Endocrine System Diseases
Arteriosclerosis
Coronary Disease
Cardiovascular Diseases
Glucose Metabolism Disorders
Coronary Artery Disease

ClinicalTrials.gov processed this record on February 08, 2010